| Mental Health Of Central Florida, Llc | |
|
929 N Us Highway 441 Ste 102 Lady Lake FL 32159-3002 | |
| (352) 633-0473 | |
| (352) 775-9562 |
| Full Name | Mental Health Of Central Florida, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 929 N Us Highway 441 Ste 102, Lady Lake, Florida |
| Authorized Official Name and Position | Ivonne M Ferrer Hopgood (OWNER) |
| Authorized Official Contact | 7876372581 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mental Health Of Central Florida, Llc 3819 Se 38th Loop Ocala FL 34480-4942 Ph: (787) 637-2581 | Mental Health Of Central Florida, Llc 929 N Us Highway 441 Ste 102 Lady Lake FL 32159-3002 Ph: (352) 633-0473 |
| NPI Number | 1497221865 |
|---|---|
| Provider Enumeration Date | 10/23/2018 |
| Last Update Date | 10/04/2021 |
| Certification Date | 10/04/2021 |
| Medicare PECOS PAC ID | 6800139411 |
|---|---|
| Medicare Enrollment ID | O20190523000695 |
News Archive
The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.
Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497221865 | NPI | - | NPPES |
| PENDING | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Ivonne Marie Ferrer |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1326216748 PECOS PAC ID: 7618210220 Enrollment ID: I20190523000918 |
News Archive
The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.
Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
› Verified 9 days ago
News Archive
The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.
Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
› Verified 9 days ago
Neuropsychiatry Centers Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 809 County Road 466 Ste 101-c, Lady Lake, FL 32159 Phone: 352-330-2020 Fax: 352-360-6582 | |
Serenity Hope Consulting Services Inc Counseling And Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13940 N Us Highway 441 Ste 210, Lady Lake, FL 32159 Phone: 919-946-0143 | |
Freedom Counseling Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 379 Fennell Blvd., Lady Lake, FL 32159 Phone: 352-633-5253 | |
Valencia Neurospina Center Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 729 County Road 466, Lady Lake, FL 32159 Phone: 352-633-1880 Fax: 352-633-1882 | |
Village Neurology Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 729 Cr 466, Lady Lake, FL 32159 Phone: 352-633-2164 Fax: 352-205-8149 | |
Villages Mind And Body Institute Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 324 S Us Highway 441, Lady Lake, FL 32159 Phone: 352-633-0614 Fax: 866-684-9990 |